Caribou Biosciences Advances CAR-T Therapy Trials

TipRanks21:37

Caribou Biosciences Starts Phase 1 Trial for Lupus Drug Candidate

MT Newswires17:47

Reported Earlier, Caribou Biosciences Advances CB-010, CB-011, And CB-012 Programs With Key Clinical Updates Expected In 2025; Cash Position $281M

Benzinga15:33

Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025

GlobeNewswire08:05

Express News | Caribou Biosciences Initiates the CB-010 Gallop Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025

Breakings08:05

BofA Securities Cuts Price Target on Caribou Biosciences to $11 From $13, Maintains Buy Rating

MT NewswiresJan 7 23:40 · Ratings